Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.
Bernard PL, Delconte R, Pastor S, Laletin V, Costa Da Silva C, Goubard A, Josselin E, Castellano R, Krug A, Vernerey J, Devillier R, Olive D, Verhoeyen E, Vivier E, Huntington ND, Nunes J, Guittard G.
Bernard PL, et al. Among authors: laletin v.
J Immunother Cancer. 2022 May;10(5):e004244. doi: 10.1136/jitc-2021-004244.
J Immunother Cancer. 2022.
PMID: 35589278
Free PMC article.